Accenture Analysts Slash Their Forecasts After Q3 Earnings

Benzinga
06-24

Accenture Plc (NYSE:ACN) posted better-than-expected third-quarter earnings on Friday.

The company reported quarterly earnings of $3.49 per share, topping the analyst consensus estimate of $3.31.

The company reported sales of $17.7 billion, slightly exceeding the analyst consensus estimate of $17.30 billion. Sales increased 8% in U.S. dollars and 7% in local currency.

“I am very pleased with our third quarter fiscal 2025 results, including our 30 clients with quarterly bookings greater than $100 million, broad-based growth and continued expansion of our leadership in Gen AI. Companies need resilience and results, and we are laser-focused on delivering measurable value for our clients, which is fueling our growth and making a difference for us in the market. I want to thank our more than 790,000 people for all they do every day to deliver on the promise of technology and human ingenuity as only Accenture can.”

Accenture narrowed its fiscal year 2025 revenue growth outlook to 6%-7% (prior 5%-7%) in local currency. The company forecasts 2025 diluted earnings of $12.77-$12.89 (prior $12.55-$12.79) per share compared to the consensus of $12.75.

Accenture shares rose 1.4% to trade at $289.35 on Monday.

These analysts made changes to their price targets on Accenture following earnings announcement.

  • BMO Capital analyst Keith Bachman maintained Accenture with a Market Perform and lowered the price target from $355 to $325.
  • Barclays analyst Ramsey El-Assal maintained the stock with an Overweight rating and lowered the price target from $390 to $360.
  • Guggenheim analyst Jonathan Lee maintained Accenture with a Buy and cut the price target from $360 to $335.

Considering buying ACN stock? Here’s what analysts think:

Read This Next:

  • Top 2 Tech Stocks That Could Sink Your Portfolio In June

Photo via Shutterstock

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10